EASE: The Materna Prep Pivotal Study

Last updated: September 16, 2025
Sponsor: Materna Medical
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Labor/delivery

Genitourinary Prolapse

Treatment

Standard of Care (SOC)

Materna Prep Device

Clinical Study ID

NCT03973281
MaternaMedical
  • Ages > 18
  • Female

Study Summary

This study is designed to evaluate the safety and effectiveness of the Materna Prep Device in reducing pelvic muscle injuries during vaginal delivery.

Subjects are randomized to Materna Prep Device or Standard of Care without use of the Materna Prep Device

Intervention with the Materna Prep Device is expected to be a one-time use of approximately 30-90 minutes during the 1st stage of labor.

Subject participation in the study is targeted to be 12 months from the time of the use of the device during delivery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Criteria for inclusion

  1. Subject is scheduled for vaginal birth.

  2. Subject is gestating a single fetus.

  3. Subject is nulliparous, or had a previous pregnancy terminated within 24 weeksgestation.

  4. Subject is able and willing to comply with the protocol required follow-up visits.

  5. Subject is able and willing to provide written informed consent prior to enrollment.

  6. In the opinion of the Investigator, the subject has sufficient mental capacity tounderstand the informed consent form (ICF), comply with the protocol requirements,and provide clinically relevant and reliable feedback regarding their experiencewith the device.

  7. Subject receives epidural anesthesia during labor prior to enrollment.

  8. Subject is 18 years of age or older at time of consent.

Exclusion

Exclusion Criteria:

Criteria for exclusion

  1. Subject has high likelihood of less than 1 hour of potential device dilation timeafter she arrives at the hospital.

  2. Subject is planning or requires a Caesarean-section prior to randomization.

  3. Subject begins labor with less than 36 weeks gestation.

  4. Subject has a neurological disorder that could cause pelvic floor dysfunction, suchas multiple sclerosis or spinal cord injury.

  5. Subject has a collagen-associated disorder that affects tissue elasticity, such asscleroderma or Ehlers-Danlos syndrome.

  6. Subject has a localized (genital tract) or systemic infection.

  7. Subject has a medical history which could lead to pelvic floor dysfunction, such asprior pelvic fractures, pelvic soft tissue injuries, or vaginal surgery.

  8. Subject has any general health condition or systemic disease that may represent, inthe opinion of the Investigator, a potential increased risk associated with deviceuse or pregnancy.

  9. Subject has placenta previa or vasa previa.

  10. Subject has known significant chromosomal or structural fetal anomalies.

  11. Subject has a category 2 and/or 3 fetal tracing that is unresolved.

  12. Subject is observed to have friable, denuded, or markedly edematous vaginal tissueduring the course of labor.

Study Design

Total Participants: 420
Treatment Group(s): 2
Primary Treatment: Standard of Care (SOC)
Phase:
Study Start date:
December 11, 2019
Estimated Completion Date:
August 30, 2026

Study Description

Vaginal delivery is a major risk factor for pelvic floor dysfunction. Clinical aspects of pelvic floor dysfunction include pelvic organ prolapse, sexual dysfunction, and fecal and urinary incontinence. Trauma to the pelvic structures occurs as the fetal head passes through the vaginal canal, especially with acute distension at the time of crowning - the exiting of the fetal head.

The Materna Prep Device is a single-use, semi-automated dilator used during the first phase of labor in order to prepare the vaginal canal for vaginal delivery. By slowly pre-stretching the vagina and surrounding pelvic tissues during labor, the device is essentially dictating the strain rate of the tissue during labor. In previous feasibility studies, the elastic recovery of the tissue has been shown to be on the order of several hours, allowing the benefits of pre-stretching the vagina and surrounding pelvic tissues to last throughout labor. The device is intended to be removed prior to the initiation of the second stage of labor, for delivery to occur unobstructed.

The target patient population for this study is nulliparous women entering the first phase of labor and scheduled for vaginal delivery with an epidural.

Connect with a study center

  • University of Alabama at Birmingham

    Birmingham, Alabama 35233
    United States

    Site Not Available

  • University of Alabama at Birmingham

    Birmingham 4049979, Alabama 4829764 35233
    United States

    Site Not Available

  • MarinHealth/La Follette Ob-Gyn and Aesthetics

    Greenbrae, California 94904
    United States

    Site Not Available

  • University of California Los Angeles

    Los Angeles, California 90095
    United States

    Site Not Available

  • El Camino Hospital

    Mountain View, California 94040
    United States

    Site Not Available

  • La Follette Ob/Gyn

    Greenbrae 5354013, California 5332921 94904
    United States

    Site Not Available

  • University of California Los Angeles

    Los Angeles 5368361, California 5332921 90095
    United States

    Site Not Available

  • El Camino Hospital

    Mountain View 5375480, California 5332921 94040
    United States

    Site Not Available

  • Christiana Care - Center for Women's & Children's Health

    Newark, Delaware 19718
    United States

    Site Not Available

  • Christiana Care - Center for Women's & Children's Health

    Newark 4143861, Delaware 4142224 19718
    United States

    Site Not Available

  • MedStar Washington Hospital Center

    Washington D.C. 4140963, District of Columbia 4138106 20010
    United States

    Site Not Available

  • USF Ob/Gyn

    Tampa 4174757, Florida 4155751 33606
    United States

    Site Not Available

  • The Healing Sanctuary

    Idaho Falls 5596475, Idaho 5596512 83404
    United States

    Site Not Available

  • Mayo Clinic

    Rochester, Minnesota 55905
    United States

    Site Not Available

  • Mayo Clinic

    Rochester 5043473, Minnesota 5037779 55905
    United States

    Site Not Available

  • The Cooper Health System

    Camden, New Jersey 08103
    United States

    Site Not Available

  • Rutgers Robert Wood Johnson University Hospital

    New Brunswick, New Jersey 08901
    United States

    Site Not Available

  • Rutgers New Jersey Medical School

    Newark, New Jersey 07103
    United States

    Site Not Available

  • The Cooper Health System

    Camden 4501018, New Jersey 5101760 08103
    United States

    Site Not Available

  • Rutgers Robert Wood Johnson University Hospital

    New Brunswick 5101717, New Jersey 5101760 08901
    United States

    Site Not Available

  • Rutgers New Jersey Medical School

    Newark 5101798, New Jersey 5101760 07103
    United States

    Site Not Available

  • Columbia University Irving Medical Center

    New York, New York 10032
    United States

    Site Not Available

  • New York Presbyterian -Queens (NYPQ)

    Flushing 5117472, New York 5128638 11355
    United States

    Site Not Available

  • Columbia University Irving Medical Center

    New York 5128581, New York 5128638 10032
    United States

    Site Not Available

  • The Metro Health System

    Cleveland, Ohio 44109
    United States

    Site Not Available

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio 43210
    United States

    Site Not Available

  • The Metro Health System

    Cleveland 5150529, Ohio 5165418 44109
    United States

    Site Not Available

  • The Ohio State University Wexner Medical Center

    Columbus 4509177, Ohio 5165418 43210
    United States

    Site Not Available

  • Oregon Health and Science University

    Portland, Oregon 97239
    United States

    Site Not Available

  • Oregon Health and Science University

    Portland 5746545, Oregon 5744337 97239
    United States

    Site Not Available

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania 19140
    United States

    Site Not Available

  • Lewis Katz School of Medicine at Temple

    Philadelphia, Pennsylvania 19140
    United States

    Site Not Available

  • Hospital of the University of Pennsylvania

    Philadelphia 4560349, Pennsylvania 6254927 19140
    United States

    Site Not Available

  • Lewis Katz School of Medicine at Temple

    Philadelphia 4560349, Pennsylvania 6254927 19140
    United States

    Site Not Available

  • Baylor College of Medicine

    Houston, Texas 77030
    United States

    Site Not Available

  • Baylor College of Medicine

    Houston 4699066, Texas 4736286 77030
    United States

    Site Not Available

  • Maximos Ob/Gyn

    League City 4705692, Texas 4736286 77573
    United States

    Site Not Available

  • Univ of Utah Ob/Gyn

    Salt Lake City 5780993, Utah 5549030 84108
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.